Sphera Biotech US Fund, L.P.

Amendment

CIK: 0001749475·Pooled Investment Fund·DELAWARE·Filed: Apr 14, 2025

Total Offering

Indefinite

Amount Sold

$32,071,088

Investors

11

First Sale

Oct 1, 2018

Offering Details

Type: Pooled Investment Fund
Exemptions: Rule 506(b), Section 3(c), Section 3(c)(7)
Entity Type: Limited Partnership
Non-Accredited Investors: No

Related Persons

Name	Role
DORON BREEN	Related Person
NIR ARKIN	Related Person
ADI HANETZ	Related Person
HANNA LERMAN	Related Person

Company

Sphera Biotech US Fund, L.P.

SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP

TEL AVIV, L3, 6777520

972-3-6845535

SEC Filing

0001749475-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.